| Literature DB >> 26798584 |
Daniela Morales-Espinosa1, Silvia García-Román1, Cristina Teixidó1, Niki Karachaliou1, Rafael Rosell1.
Abstract
Cancer treatment as we know it today has dramatically changed over the last couple of decades. It has moved from non-specific treatment to personalized approaches. As oncologist, we now have further understanding of the processes leading to carcinogenesis; this has led to develop new therapeutic options. We have cytotoxic treatments, targeted therapy and in recent years, immunotherapy; the time to "mix and match" has begun.Entities:
Keywords: Immunotherapy; cancer; combination therapy; personalized treatment; targeted therapy
Year: 2015 PMID： 26798584 PMCID： PMC4700229 DOI： 10.3978/j.issn.2218-6751.2015.12.05
Source DB: PubMed Journal: Transl Lung Cancer Res ISSN： 2218-6751